SS
PASG icon

SBI Securities’s Passage Bio PASG Stock Holding History

SBI Securities’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$825 Buy
169
+45
+36% +$282 ﹤0.01% 2872
2026
Q1 		$973 Sell
124
-18
-13% -$186 ﹤0.01% 2665
2025
Q4 		$1.68K Hold
142
– – ﹤0.01% 2455
2025
Q3 		$1.14K Sell
142
-3
-2% -$21 ﹤0.01% 2641
2025
Q2 		$1.16K Sell
145
-119
-45% -$869 ﹤0.01% 2620
2025
Q1 		$1.86K Buy
264
+146
+124% +$1.58K ﹤0.01% 2320
2024
Q4 		$1.34K Buy
+118
New +$1.54K ﹤0.01% 2478

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

SBI Securities's PASG Position: Q2 2026 in Review

SBI Securities increased its Passage Bio (PASG) stake by 36% in Q2 2026, buying an estimated $282 and bringing the position to 169 shares worth $825. The position accounts for ﹤0.01% of the portfolio, ranked #2872.

SBI Securities first reported a position in PASG in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.86K in Q1 2025. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • SBI Securities held 169 shares of Passage Bio worth $825 as of Q2 2026.
  • SBI Securities bought 45 Passage Bio shares in Q2 2026, an estimated $282.
  • Passage Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2872 holding.
  • SBI Securities first reported a position in Passage Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Passage Bio position peaked at $1.86K in Q1 2025.
  • 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.